Partner William R. Golden spoke at the American Conference Institute's 9th Annual conference titled "Maximizing Pharmaceutical Patent Life Cycles" on October 15–16, 2008. Industry leaders guided inside and outside patent attorneys on analyzing the complex issues, evaluating options and benchmarking strategies against competitors on either side of the branded-generic battle. Mr. Golden's program focused on navigating the complexity of structuring patent settlement options between brand name and generic pharmaceutical companies.